Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2015-07-01

FDA Approved: BROMFENAC OPHTHALMIC SOLUTION — Supplemental Application (Bausch & Lomb Americas Inc.)

View source ↗

Summary

The FDA approved a supplemental application for Bromfenac Ophthalmic Solution (bromfenac sodium) from Bausch & Lomb Americas, expanding its labeling for postope…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Bromfenac Ophthalmic Solution (bromfenac sodium)

Snippet

SUPPL AP for BROMFENAC OPHTHALMIC SOLUTION (BROMFENAC SODIUM)